SEPARATION AND GENERAL RELEASE AGREEMENTSeparation and General Release Agreement • November 10th, 2011 • CorMedix Inc. • Pharmaceutical preparations
This Separation and General Release Agreement must be executed and returned to Employer on or after September 30, 2011 but before October 21, 2011.
AMENDMENT NO. 3 TO CONTRIBUTION AGREEMENTContribution Agreement • November 10th, 2011 • CorMedix Inc. • Pharmaceutical preparations
This AMENDMENT NO. 3 TO CONTRIBUTION AGREEMENT (this “Amendment”), is executed as of August 31, 2011, by and between Shiva Biomedical, LLC, a New Jersey limited liability company having a business address of 10810 Executive Drive, Danville Building, Suite 100, Little Rock, Arkansas 22211 (“Shiva”), and CorMedix, Inc., formerly Picton Holding Company, Inc. (“Holdings”) and successor in interest to Picton Pharmaceuticals, Inc. (“Picton”), a Delaware corporation having a business address of 745 Route 202-206, Suite 303, Bridgewater, NJ 08807 (the “Company”).
